Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)

Q: What does CUSIP 92337R101 represent in this 13F holders report?

CUSIP 92337R101 is the security identifier for VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share in Q1 2026?

227 institutional investors reported VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: 92337R101

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Class A Common Stock, par value $0.001 per share
Shares outstanding: 72,325,000
Total 13F shares: 72,234,409
Share change: -1,748,286
Total reported value: $2,918,504,853
Put/Call ratio: 8.3%
Price per share: $40.23
Number of holders: 227
Value change: -$101,315,946
Number of buys: 133
Number of sells: 93

Security key

92337R101

Report period

Q1 2026

Institutions

227

Top holders

VERA full security history Ownership snapshot Full 13F holder table Previous quarter: Q4 2025 Vera Therapeutics, Inc. SEC filings Vera Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 92337R101

Previous quarter: Q4 2025

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top shareholders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Avoro Capital Advisors LLC

13D/G signal

Avoro Capital Advisors LLC

Evidence rows

Latest as of

04 Mar 2026

13F 13D/G 3/4/5 Lead comparable stake: 8.9% 13D/G row: Avoro Capital Advisors LLC Showing first 8 of 50 holder rows. Open remaining rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Avoro Capital Advisors LLC	13F 13D/G Company 13F 13D/G	8.9% from 13D/G	$298,213,288 5,888,888 shares	—	31 Dec 2025
PRICE T ROWE ASSOCIATES INC /MD/	13D/G 13F T. Rowe Price Associates, Inc. · Company 13D/G 13F	7.7%	$276,595,072 5,461,988 shares	+$90,918,550	31 Dec 2025
Deep Track Capital, LP	13D/G 13F Company 13D/G 13F	5.5%	$176,892,640 3,921,362 shares	$0	04 Mar 2026
Kynam Capital Management, LP	13F 13D/G Company 13F 13D/G	5.4% from 13D/G	$173,849,703 3,433,051 shares	—	31 Dec 2025
James E. Flynn	13D/G Deerfield Mgmt, L.P. 13D/G	5.2%	$75,299,151 3,348,117 shares	$0	06 Jun 2025
VANGUARD GROUP INC	13F 13D/G Company · The Vanguard Group 13F 13D/G	5% from 13D/G	$180,805,107 3,570,401 shares	—	31 Dec 2025
FMR LLC	13F 13D/G Company 13F 13D/G	4.1% from 13D/G	$146,139,597 2,885,853 shares	—	31 Dec 2025
Sofinnova Venture Partners X, L.P.	13D/G 3/4/5 Dr. Maha Katabi ("Katabi") · 10%+ Owner 13D/G 3/4/5	4%	$128,465,927 2,847,837 shares	$0	10 Dec 2025

Show 42 additional holder rows in the full holder list

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Point72 Asset Management, L.P.	13F 13D/G Company 13F 13D/G	1.7% from 13D/G	$88,031,816 1,738,385 shares	—	31 Dec 2025
Jason S. Carter	3/4/5 Chief Legal Officer 3/4/5	0.07%	$1,366,983 49,136 shares	-$107,498	21 Nov 2025
BlackRock, Inc.	13F Company 13F	6.7%	$244,364,280 4,825,519 shares	—	31 Dec 2025
DEERFIELD MANAGEMENT COMPANY, L.P.	13F Company 13F	5.6%	$205,582,955 4,059,695 shares	—	31 Dec 2025
Eversept Partners, LP	13F Company 13F	4.2%	$155,581,475 3,072,304 shares	—	31 Dec 2025
Sofinnova Investments, Inc.	13F Company 13F	3.9%	$141,487,502 2,793,987 shares	—	31 Dec 2025
STATE STREET CORP	13F Company 13F	3.7%	$135,543,024 2,676,600 shares	—	31 Dec 2025
Integral Health Asset Management, LLC	13F Company 13F	2.5%	$91,152,000 1,800,000 shares	—	31 Dec 2025
Bellevue Group AG	13F Company 13F	2.3%	$85,994,417 1,698,152 shares	—	31 Dec 2025
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	2%	$73,185,024 1,444,925 shares	—	31 Dec 2025
Pictet Asset Management Holding SA	13F Company 13F	1.9%	$70,512,199 1,392,421 shares	—	31 Dec 2025
Holocene Advisors, LP	13F Company 13F	1.8%	$66,206,382 1,307,393 shares	—	31 Dec 2025
ALLIANCEBERNSTEIN L.P.	13F Company 13F	1.7%	$61,712,790 1,218,657 shares	—	31 Dec 2025
GOLDMAN SACHS GROUP INC	13F Company 13F	1.5%	$56,756,299 1,120,780 shares	—	31 Dec 2025
Woodline Partners LP	13F Company 13F	1.4%	$50,654,129 1,000,279 shares	—	31 Dec 2025
First Light Asset Management, LLC	13F Company 13F	1.2%	$44,040,393 869,676 shares	—	31 Dec 2025
Tri Locum Partners LP	13F Company 13F	1.1%	$40,800,091 805,689 shares	—	31 Dec 2025
BRAIDWELL LP	13F Company 13F	1.1%	$39,739,335 784,742 shares	—	31 Dec 2025
CITADEL ADVISORS LLC	13F Company 13F	1.1%	$39,371,992 777,488 shares	—	31 Dec 2025
AMERICAN CENTURY COMPANIES INC	13F Company 13F	1%	$37,103,945 732,699 shares	—	31 Dec 2025
BANK OF AMERICA CORP /DE/	13F Company 13F	0.96%	$35,160,313 694,319 shares	—	31 Dec 2025
ARMISTICE CAPITAL, LLC	13F Company 13F	0.9%	$33,108,229 653,796 shares	—	31 Dec 2025
First Turn Management, LLC	13F Company 13F	0.83%	$30,473,835 601,774 shares	—	31 Dec 2025
Rock Springs Capital Management LP	13F Company 13F	0.79%	$28,792,841 568,579 shares	—	31 Dec 2025
Vestal Point Capital, LP	13F Company 13F	0.76%	$27,852,000 550,000 shares	—	31 Dec 2025
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F Company 13F	0.72%	$26,274,969 518,858 shares	—	31 Dec 2025
MORGAN STANLEY	13F Company 13F	0.69%	$25,303,052 499,665 shares	—	31 Dec 2025
Elmind Capital, LP	13F Company 13F	0.67%	$24,433,800 482,500 shares	—	31 Dec 2025
BNP PARIBAS FINANCIAL MARKETS	13F Company 13F	0.66%	$24,037,188 474,668 shares	—	31 Dec 2025
NORTHERN TRUST CORP	13F Company 13F	0.65%	$23,963,810 473,219 shares	—	31 Dec 2025
S.c.a. Candriam	13F Individual 13F	0.62%	$22,766,384 449,554 shares	—	31 Dec 2025
Rhenman & Partners Asset Management AB	13F Company 13F	0.58%	$21,268,800 420,000 shares	—	31 Dec 2025
VOYA INVESTMENT MANAGEMENT LLC	13F Company 13F	0.58%	$21,216,287 418,963 shares	—	31 Dec 2025
Qube Research & Technologies Ltd	13F Company 13F	0.52%	$19,144,705 378,055 shares	—	31 Dec 2025
FRONTIER CAPITAL MANAGEMENT CO LLC	13F Company 13F	0.51%	$18,795,087 371,151 shares	—	31 Dec 2025
ORBIMED ADVISORS LLC	13F Company 13F	0.49%	$17,901,240 353,500 shares	—	31 Dec 2025
DIMENSIONAL FUND ADVISORS LP	13F Company 13F	0.49%	$17,819,507 351,886 shares	—	31 Dec 2025
DEUTSCHE BANK AG\	13F Company 13F	0.48%	$17,593,653 347,426 shares	—	31 Dec 2025
TD ASSET MANAGEMENT INC	13F Company 13F	0.45%	$16,486,561 325,564 shares	—	31 Dec 2025
BARCLAYS PLC	13F Company 13F	0.35%	$12,848,179 253,716 shares	—	31 Dec 2025
TimesSquare Capital Management, LLC	13F Company 13F	0.35%	$12,784,676 252,462 shares	—	31 Dec 2025
Affinity Asset Advisors, LLC	13F Company 13F	0.35%	$12,660,000 250,000 shares	—	31 Dec 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

227

72,234,409

Rows loaded

227

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

214

Q1 2026 holders

227

Holder diff

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 value	Q1 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend